Signaling Pathways
-
A3887 Trametinib DMSO solvate1 CitationTarget: MEKSummary: Allosteric MEK1/MEK2 kinase inhibitor
-
A3894 TTP 221 CitationTarget: CK2Summary: CK2 inhibitor
-
A3895 TUG-770Target: Free Fatty Acid ReceptorsSummary: FFA1/GPR40 agonist
-
A3927 VS-5584 (SB2343)Target: PI3K|mTORSummary: MTOR/P13K inhibitor,potent and selective
-
A3931 VX-11e5 CitationTarget: ERKSummary: ERK inhibitor
-
A3935 WEHI-53915 CitationTarget: Bcl-xlSummary: Bcl-xL inhibitor,potent and selective
-
A3937 XL019Target: JAKSummary: JAK2 inhibitor,potent and selective
-
A3942 XMD17-109Target: ERKSummary: ERK-5 inhibitor
-
A3943 XMD8-92Target: ERKSummary: BMK1/ERK5 inhibitor
-
A3944 X-NeuNAcTarget: Neuraminidases (NA)Summary: Subtrate for chromogeneic assay of neuraminidase activity